<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Details for gene set KEGG_THYROID_CANCER[GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='keyValTable'><table cols='2' border='0'><th class='keyValTable'></th><th class='keyValTable'></th><tr><td>Dataset</td><td>normalized_counts_PCI_GSEAv1_collapsed_to_symbols.phenotype_data_PCI_v1.cls<br>#PCIHigh_versus_PCILow</td></tr><tr><td>Phenotype</td><td>phenotype_data_PCI_v1.cls#PCIHigh_versus_PCILow</td></tr><tr><td>Upregulated in class</td><td>PCILow</td></tr><tr><td>GeneSet</td><td>KEGG_THYROID_CANCER</td></tr><tr><td>Enrichment Score (ES)</td><td>-0.36010945</td></tr><tr><td>Normalized Enrichment Score (NES)</td><td>-1.2566581</td></tr><tr><td>Nominal p-value</td><td>0.17021276</td></tr><tr><td>FDR q-value</td><td>1.0</td></tr><tr><td>FWER p-Value</td><td>1.0</td></tr><caption class='table'>Table: GSEA Results Summary</caption></table></div><br><div class='image'><img name='enplot_KEGG_THYROID_CANCER' src='enplot_KEGG_THYROID_CANCER_584.png'><br><br><caption>Fig 1: Enrichment plot: KEGG_THYROID_CANCER &nbsp&nbsp <br> Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List</caption></div><br><div class='richTable'><table cols='7' border='1'><th class='richTable'></th><th class='richTable'>SYMBOL</th><th class='richTable'>TITLE</th><th class='richTable'>RANK IN GENE LIST</th><th class='richTable'>RANK METRIC SCORE</th><th class='richTable'>RUNNING ES</th><th class='richTable'>CORE ENRICHMENT</th><tr><td class='lessen'>1</td><td><a href='https://ensembl.org/Search/Results?q=RXRB'>RXRB</a></td><td>retinoid X receptor beta [Source:HGNC Symbol;Acc:HGNC:10478]</td><td>683</td><td>0.257</td><td>0.0379</td><td>No</td></tr><tr><td class='lessen'>2</td><td><a href='https://ensembl.org/Search/Results?q=RET'>RET</a></td><td>ret proto-oncogene [Source:HGNC Symbol;Acc:HGNC:9967]</td><td>795</td><td>0.243</td><td>0.1032</td><td>No</td></tr><tr><td class='lessen'>3</td><td><a href='https://ensembl.org/Search/Results?q=PAX8'>PAX8</a></td><td>paired box 8 [Source:HGNC Symbol;Acc:HGNC:8622]</td><td>1480</td><td>0.192</td><td>0.1220</td><td>No</td></tr><tr><td class='lessen'>4</td><td><a href='https://ensembl.org/Search/Results?q=NTRK1'>NTRK1</a></td><td>neurotrophic receptor tyrosine kinase 1 [Source:HGNC Symbol;Acc:HGNC:8031]</td><td>2482</td><td>0.145</td><td>0.1097</td><td>No</td></tr><tr><td class='lessen'>5</td><td><a href='https://ensembl.org/Search/Results?q=TP53'>TP53</a></td><td>tumor protein p53 [Source:HGNC Symbol;Acc:HGNC:11998]</td><td>3522</td><td>0.112</td><td>0.0856</td><td>No</td></tr><tr><td class='lessen'>6</td><td><a href='https://ensembl.org/Search/Results?q=HRAS'>HRAS</a></td><td>HRas proto-oncogene, GTPase [Source:HGNC Symbol;Acc:HGNC:5173]</td><td>5073</td><td>0.074</td><td>0.0223</td><td>No</td></tr><tr><td class='lessen'>7</td><td><a href='https://ensembl.org/Search/Results?q=MAPK3'>MAPK3</a></td><td>mitogen-activated protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:6877]</td><td>5144</td><td>0.073</td><td>0.0398</td><td>No</td></tr><tr><td class='lessen'>8</td><td><a href='https://ensembl.org/Search/Results?q=CCND1'>CCND1</a></td><td>cyclin D1 [Source:HGNC Symbol;Acc:HGNC:1582]</td><td>5323</td><td>0.069</td><td>0.0503</td><td>No</td></tr><tr><td class='lessen'>9</td><td><a href='https://ensembl.org/Search/Results?q=RXRA'>RXRA</a></td><td>retinoid X receptor alpha [Source:HGNC Symbol;Acc:HGNC:10477]</td><td>6547</td><td>0.042</td><td>-0.0046</td><td>No</td></tr><tr><td class='lessen'>10</td><td><a href='https://ensembl.org/Search/Results?q=TCF7'>TCF7</a></td><td>transcription factor 7 [Source:HGNC Symbol;Acc:HGNC:11639]</td><td>8037</td><td>0.012</td><td>-0.0828</td><td>No</td></tr><tr><td class='lessen'>11</td><td><a href='https://ensembl.org/Search/Results?q=LEF1'>LEF1</a></td><td>lymphoid enhancer binding factor 1 [Source:HGNC Symbol;Acc:HGNC:6551]</td><td>8638</td><td>0.000</td><td>-0.1156</td><td>No</td></tr><tr><td class='lessen'>12</td><td><a href='https://ensembl.org/Search/Results?q=CCDC6'>CCDC6</a></td><td>coiled-coil domain containing 6 [Source:HGNC Symbol;Acc:HGNC:18782]</td><td>10078</td><td>-0.004</td><td>-0.1935</td><td>No</td></tr><tr><td class='lessen'>13</td><td><a href='https://ensembl.org/Search/Results?q=CDH1'>CDH1</a></td><td>cadherin 1 [Source:HGNC Symbol;Acc:HGNC:1748]</td><td>10290</td><td>-0.008</td><td>-0.2027</td><td>No</td></tr><tr><td class='lessen'>14</td><td><a href='https://ensembl.org/Search/Results?q=TPM3'>TPM3</a></td><td>tropomyosin 3 [Source:HGNC Symbol;Acc:HGNC:12012]</td><td>11494</td><td>-0.033</td><td>-0.2591</td><td>No</td></tr><tr><td class='lessen'>15</td><td><a href='https://ensembl.org/Search/Results?q=TCF7L2'>TCF7L2</a></td><td>transcription factor 7 like 2 [Source:HGNC Symbol;Acc:HGNC:11641]</td><td>12285</td><td>-0.049</td><td>-0.2881</td><td>No</td></tr><tr><td class='lessen'>16</td><td><a href='https://ensembl.org/Search/Results?q=TCF7L1'>TCF7L1</a></td><td>transcription factor 7 like 1 [Source:HGNC Symbol;Acc:HGNC:11640]</td><td>12462</td><td>-0.052</td><td>-0.2824</td><td>No</td></tr><tr><td class='lessen'>17</td><td><a href='https://ensembl.org/Search/Results?q=MAPK1'>MAPK1</a></td><td>mitogen-activated protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:6871]</td><td>13239</td><td>-0.071</td><td>-0.3042</td><td>No</td></tr><tr><td class='lessen'>18</td><td><a href='https://ensembl.org/Search/Results?q=RXRG'>RXRG</a></td><td>retinoid X receptor gamma [Source:HGNC Symbol;Acc:HGNC:10479]</td><td>13249</td><td>-0.071</td><td>-0.2840</td><td>No</td></tr><tr><td class='lessen'>19</td><td><a href='https://ensembl.org/Search/Results?q=MAP2K2'>MAP2K2</a></td><td>mitogen-activated protein kinase kinase 2 [Source:HGNC Symbol;Acc:HGNC:6842]</td><td>13691</td><td>-0.081</td><td>-0.2842</td><td>No</td></tr><tr><td class='lessen'>20</td><td><a href='https://ensembl.org/Search/Results?q=NCOA4'>NCOA4</a></td><td>nuclear receptor coactivator 4 [Source:HGNC Symbol;Acc:HGNC:7671]</td><td>14149</td><td>-0.093</td><td>-0.2821</td><td>No</td></tr><tr><td class='lessen'>21</td><td><a href='https://ensembl.org/Search/Results?q=TFG'>TFG</a></td><td>trafficking from ER to golgi regulator [Source:HGNC Symbol;Acc:HGNC:11758]</td><td>14458</td><td>-0.101</td><td>-0.2694</td><td>No</td></tr><tr><td class='lessen'>22</td><td><a href='https://ensembl.org/Search/Results?q=MAP2K1'>MAP2K1</a></td><td>mitogen-activated protein kinase kinase 1 [Source:HGNC Symbol;Acc:HGNC:6840]</td><td>14757</td><td>-0.109</td><td>-0.2535</td><td>No</td></tr><tr><td class='lessen'>23</td><td><a href='https://ensembl.org/Search/Results?q=BRAF'>BRAF</a></td><td>B-Raf proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:1097]</td><td>16700</td><td>-0.179</td><td>-0.3076</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>24</td><td><a href='https://ensembl.org/Search/Results?q=MYC'>MYC</a></td><td>MYC proto-oncogene, bHLH transcription factor [Source:HGNC Symbol;Acc:HGNC:7553]</td><td>16876</td><td>-0.188</td><td>-0.2620</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>25</td><td><a href='https://ensembl.org/Search/Results?q=CTNNB1'>CTNNB1</a></td><td>catenin beta 1 [Source:HGNC Symbol;Acc:HGNC:2514]</td><td>17360</td><td>-0.219</td><td>-0.2240</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>26</td><td><a href='https://ensembl.org/Search/Results?q=NRAS'>NRAS</a></td><td>NRAS proto-oncogene, GTPase [Source:HGNC Symbol;Acc:HGNC:7989]</td><td>17400</td><td>-0.222</td><td>-0.1608</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>27</td><td><a href='https://ensembl.org/Search/Results?q=TPR'>TPR</a></td><td>translocated promoter region, nuclear basket protein [Source:HGNC Symbol;Acc:HGNC:12017]</td><td>17447</td><td>-0.226</td><td>-0.0970</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>28</td><td><a href='https://ensembl.org/Search/Results?q=KRAS'>KRAS</a></td><td>KRAS proto-oncogene, GTPase [Source:HGNC Symbol;Acc:HGNC:6407]</td><td>17461</td><td>-0.228</td><td>-0.0309</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>29</td><td><a href='https://ensembl.org/Search/Results?q=PPARG'>PPARG</a></td><td>peroxisome proliferator activated receptor gamma [Source:HGNC Symbol;Acc:HGNC:9236]</td><td>17680</td><td>-0.253</td><td>0.0314</td><td bgcolor='#CCFFCC'>Yes</td></tr><caption class='table'>Table: GSEA details&nbsp<a href='KEGG_THYROID_CANCER.tsv'>[plain text format]</a></caption></table></div><br><div class='image'><img name='KEGG_THYROID_CANCER' src='KEGG_THYROID_CANCER_585.png'><br><br><caption>Fig 2: KEGG_THYROID_CANCER &nbsp&nbsp <br> Blue-Pink O' Gram in the Space of the Analyzed GeneSet</caption></div><br><div class='image'><img name='gset_rnd_es_dist' src='gset_rnd_es_dist_586.png'><br><br><caption>Fig 3: KEGG_THYROID_CANCER: Random ES distribution &nbsp&nbsp <br> Gene set null distribution of ES for <b>KEGG_THYROID_CANCER</b></caption></div><br></body></html>